nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxylamine—Dimetacrine—ACHE—kidney cancer	0.00605	0.478	CrCbGaD
Doxylamine—Toremifene—CYP1A1—kidney cancer	0.00198	0.156	CrCbGaD
Doxylamine—Hypersensitivity—Everolimus—kidney cancer	0.0014	0.00142	CcSEcCtD
Doxylamine—Leukopenia—Gemcitabine—kidney cancer	0.0014	0.00141	CcSEcCtD
Doxylamine—Flushing—Paclitaxel—kidney cancer	0.00139	0.00141	CcSEcCtD
Doxylamine—Cardiac disorder—Paclitaxel—kidney cancer	0.00139	0.00141	CcSEcCtD
Doxylamine—Decreased appetite—Sunitinib—kidney cancer	0.00138	0.0014	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00137	0.00139	CcSEcCtD
Doxylamine—Asthenia—Vinblastine—kidney cancer	0.00137	0.00138	CcSEcCtD
Doxylamine—Fatigue—Sunitinib—kidney cancer	0.00137	0.00138	CcSEcCtD
Doxylamine—Depression—Capecitabine—kidney cancer	0.00137	0.00138	CcSEcCtD
Doxylamine—Asthenia—Everolimus—kidney cancer	0.00136	0.00138	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.00136	0.00138	CcSEcCtD
Doxylamine—Constipation—Sunitinib—kidney cancer	0.00136	0.00137	CcSEcCtD
Doxylamine—Immune system disorder—Paclitaxel—kidney cancer	0.00135	0.00137	CcSEcCtD
Doxylamine—Mediastinal disorder—Paclitaxel—kidney cancer	0.00135	0.00137	CcSEcCtD
Doxylamine—Pruritus—Everolimus—kidney cancer	0.00134	0.00136	CcSEcCtD
Doxylamine—Anaphylactic shock—Vincristine—kidney cancer	0.00134	0.00136	CcSEcCtD
Doxylamine—Nervous system disorder—Vincristine—kidney cancer	0.00132	0.00133	CcSEcCtD
Doxylamine—Asthenia—Erlotinib—kidney cancer	0.00131	0.00133	CcSEcCtD
Doxylamine—Thrombocytopenia—Vincristine—kidney cancer	0.00131	0.00133	CcSEcCtD
Doxylamine—Discomfort—Gemcitabine—kidney cancer	0.00131	0.00133	CcSEcCtD
Doxylamine—Urticaria—Sorafenib—kidney cancer	0.00131	0.00133	CcSEcCtD
Doxylamine—Erythema—Paclitaxel—kidney cancer	0.00131	0.00132	CcSEcCtD
Doxylamine—Decreased appetite—Dactinomycin—kidney cancer	0.0013	0.00132	CcSEcCtD
Doxylamine—Diarrhoea—Vinblastine—kidney cancer	0.0013	0.00132	CcSEcCtD
Doxylamine—Diarrhoea—Everolimus—kidney cancer	0.0013	0.00132	CcSEcCtD
Doxylamine—Hyperhidrosis—Vincristine—kidney cancer	0.0013	0.00131	CcSEcCtD
Doxylamine—Pruritus—Erlotinib—kidney cancer	0.0013	0.00131	CcSEcCtD
Doxylamine—Fatigue—Dactinomycin—kidney cancer	0.00129	0.00131	CcSEcCtD
Doxylamine—Agranulocytosis—Capecitabine—kidney cancer	0.00128	0.0013	CcSEcCtD
Doxylamine—Anorexia—Vincristine—kidney cancer	0.00128	0.00129	CcSEcCtD
Doxylamine—Anaphylactic shock—Gemcitabine—kidney cancer	0.00127	0.00129	CcSEcCtD
Doxylamine—Dizziness—Vinblastine—kidney cancer	0.00126	0.00128	CcSEcCtD
Doxylamine—Dizziness—Everolimus—kidney cancer	0.00126	0.00127	CcSEcCtD
Doxylamine—Muscle spasms—Paclitaxel—kidney cancer	0.00125	0.00127	CcSEcCtD
Doxylamine—Diarrhoea—Erlotinib—kidney cancer	0.00125	0.00127	CcSEcCtD
Doxylamine—Hypotension—Vincristine—kidney cancer	0.00125	0.00127	CcSEcCtD
Doxylamine—Bradycardia—Capecitabine—kidney cancer	0.00125	0.00127	CcSEcCtD
Doxylamine—Nervous system disorder—Gemcitabine—kidney cancer	0.00125	0.00126	CcSEcCtD
Doxylamine—Thrombocytopenia—Gemcitabine—kidney cancer	0.00125	0.00126	CcSEcCtD
Doxylamine—Feeling abnormal—Dactinomycin—kidney cancer	0.00124	0.00125	CcSEcCtD
Doxylamine—Hepatitis—Capecitabine—kidney cancer	0.00123	0.00125	CcSEcCtD
Doxylamine—Hyperhidrosis—Gemcitabine—kidney cancer	0.00123	0.00125	CcSEcCtD
Doxylamine—Tremor—Paclitaxel—kidney cancer	0.00122	0.00124	CcSEcCtD
Doxylamine—Urinary tract disorder—Capecitabine—kidney cancer	0.00122	0.00123	CcSEcCtD
Doxylamine—Hypersensitivity—Sorafenib—kidney cancer	0.00121	0.00123	CcSEcCtD
Doxylamine—Insomnia—Vincristine—kidney cancer	0.00121	0.00123	CcSEcCtD
Doxylamine—Anorexia—Gemcitabine—kidney cancer	0.00121	0.00123	CcSEcCtD
Doxylamine—Vomiting—Vinblastine—kidney cancer	0.00121	0.00123	CcSEcCtD
Doxylamine—Dizziness—Erlotinib—kidney cancer	0.00121	0.00123	CcSEcCtD
Doxylamine—Ill-defined disorder—Paclitaxel—kidney cancer	0.00121	0.00123	CcSEcCtD
Doxylamine—Vomiting—Everolimus—kidney cancer	0.00121	0.00122	CcSEcCtD
Doxylamine—Urethral disorder—Capecitabine—kidney cancer	0.00121	0.00122	CcSEcCtD
Doxylamine—Agitation—Paclitaxel—kidney cancer	0.0012	0.00121	CcSEcCtD
Doxylamine—Rash—Everolimus—kidney cancer	0.0012	0.00121	CcSEcCtD
Doxylamine—Dermatitis—Everolimus—kidney cancer	0.0012	0.00121	CcSEcCtD
Doxylamine—Angioedema—Paclitaxel—kidney cancer	0.00119	0.00121	CcSEcCtD
Doxylamine—Hypotension—Gemcitabine—kidney cancer	0.00119	0.0012	CcSEcCtD
Doxylamine—Asthenia—Sorafenib—kidney cancer	0.00118	0.0012	CcSEcCtD
Doxylamine—Malaise—Paclitaxel—kidney cancer	0.00118	0.00119	CcSEcCtD
Doxylamine—Vertigo—Paclitaxel—kidney cancer	0.00117	0.00119	CcSEcCtD
Doxylamine—Leukopenia—Paclitaxel—kidney cancer	0.00117	0.00118	CcSEcCtD
Doxylamine—Hypersensitivity—Sunitinib—kidney cancer	0.00117	0.00118	CcSEcCtD
Doxylamine—Decreased appetite—Vincristine—kidney cancer	0.00117	0.00118	CcSEcCtD
Doxylamine—Pruritus—Sorafenib—kidney cancer	0.00117	0.00118	CcSEcCtD
Doxylamine—Vomiting—Erlotinib—kidney cancer	0.00116	0.00118	CcSEcCtD
Doxylamine—Erythema multiforme—Capecitabine—kidney cancer	0.00116	0.00118	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Vincristine—kidney cancer	0.00116	0.00117	CcSEcCtD
Doxylamine—Fatigue—Vincristine—kidney cancer	0.00116	0.00117	CcSEcCtD
Doxylamine—Rash—Erlotinib—kidney cancer	0.00115	0.00117	CcSEcCtD
Doxylamine—Dermatitis—Erlotinib—kidney cancer	0.00115	0.00117	CcSEcCtD
Doxylamine—Palpitations—Paclitaxel—kidney cancer	0.00115	0.00117	CcSEcCtD
Doxylamine—Insomnia—Gemcitabine—kidney cancer	0.00115	0.00117	CcSEcCtD
Doxylamine—Eye disorder—Capecitabine—kidney cancer	0.00115	0.00116	CcSEcCtD
Doxylamine—Constipation—Vincristine—kidney cancer	0.00115	0.00116	CcSEcCtD
Doxylamine—Diplopia—Doxorubicin—kidney cancer	0.00115	0.00116	CcSEcCtD
Doxylamine—Cardiac disorder—Capecitabine—kidney cancer	0.00114	0.00116	CcSEcCtD
Doxylamine—Flushing—Capecitabine—kidney cancer	0.00114	0.00116	CcSEcCtD
Doxylamine—Asthenia—Sunitinib—kidney cancer	0.00114	0.00115	CcSEcCtD
Doxylamine—Dyspnoea—Gemcitabine—kidney cancer	0.00113	0.00115	CcSEcCtD
Doxylamine—Nausea—Vinblastine—kidney cancer	0.00113	0.00115	CcSEcCtD
Doxylamine—Somnolence—Gemcitabine—kidney cancer	0.00113	0.00115	CcSEcCtD
Doxylamine—Convulsion—Paclitaxel—kidney cancer	0.00113	0.00115	CcSEcCtD
Doxylamine—Affect lability—Doxorubicin—kidney cancer	0.00113	0.00114	CcSEcCtD
Doxylamine—Nausea—Everolimus—kidney cancer	0.00113	0.00114	CcSEcCtD
Doxylamine—Diarrhoea—Sorafenib—kidney cancer	0.00113	0.00114	CcSEcCtD
Doxylamine—Pruritus—Sunitinib—kidney cancer	0.00112	0.00114	CcSEcCtD
Doxylamine—Immune system disorder—Capecitabine—kidney cancer	0.00111	0.00113	CcSEcCtD
Doxylamine—Mediastinal disorder—Capecitabine—kidney cancer	0.00111	0.00112	CcSEcCtD
Doxylamine—Anxiety—Paclitaxel—kidney cancer	0.00111	0.00112	CcSEcCtD
Doxylamine—Decreased appetite—Gemcitabine—kidney cancer	0.00111	0.00112	CcSEcCtD
Doxylamine—Hypersensitivity—Dactinomycin—kidney cancer	0.00111	0.00112	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.0011	0.00111	CcSEcCtD
Doxylamine—Discomfort—Paclitaxel—kidney cancer	0.0011	0.00111	CcSEcCtD
Doxylamine—Fatigue—Gemcitabine—kidney cancer	0.0011	0.00111	CcSEcCtD
Doxylamine—Dizziness—Sorafenib—kidney cancer	0.00109	0.0011	CcSEcCtD
Doxylamine—Constipation—Gemcitabine—kidney cancer	0.00109	0.0011	CcSEcCtD
Doxylamine—Nausea—Erlotinib—kidney cancer	0.00109	0.0011	CcSEcCtD
Doxylamine—Dry mouth—Paclitaxel—kidney cancer	0.00109	0.0011	CcSEcCtD
Doxylamine—Mood swings—Doxorubicin—kidney cancer	0.00109	0.0011	CcSEcCtD
Doxylamine—Diarrhoea—Sunitinib—kidney cancer	0.00108	0.0011	CcSEcCtD
Doxylamine—Asthenia—Dactinomycin—kidney cancer	0.00108	0.00109	CcSEcCtD
Doxylamine—Confusional state—Paclitaxel—kidney cancer	0.00107	0.00109	CcSEcCtD
Doxylamine—Erythema—Capecitabine—kidney cancer	0.00107	0.00108	CcSEcCtD
Doxylamine—Dehydration—Doxorubicin—kidney cancer	0.00107	0.00108	CcSEcCtD
Doxylamine—Anaphylactic shock—Paclitaxel—kidney cancer	0.00107	0.00108	CcSEcCtD
Doxylamine—Toremifene—ABCB1—kidney cancer	0.00105	0.083	CrCbGaD
Doxylamine—Dizziness—Sunitinib—kidney cancer	0.00105	0.00106	CcSEcCtD
Doxylamine—Feeling abnormal—Gemcitabine—kidney cancer	0.00105	0.00106	CcSEcCtD
Doxylamine—Vomiting—Sorafenib—kidney cancer	0.00105	0.00106	CcSEcCtD
Doxylamine—Orthostatic hypotension—Doxorubicin—kidney cancer	0.00105	0.00106	CcSEcCtD
Doxylamine—Nervous system disorder—Paclitaxel—kidney cancer	0.00104	0.00106	CcSEcCtD
Doxylamine—Thrombocytopenia—Paclitaxel—kidney cancer	0.00104	0.00106	CcSEcCtD
Doxylamine—Tachycardia—Paclitaxel—kidney cancer	0.00104	0.00105	CcSEcCtD
Doxylamine—Rash—Sorafenib—kidney cancer	0.00104	0.00105	CcSEcCtD
Doxylamine—Dermatitis—Sorafenib—kidney cancer	0.00104	0.00105	CcSEcCtD
Doxylamine—Breast disorder—Doxorubicin—kidney cancer	0.00104	0.00105	CcSEcCtD
Doxylamine—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.00103	0.00105	CcSEcCtD
Doxylamine—Muscle spasms—Capecitabine—kidney cancer	0.00103	0.00104	CcSEcCtD
Doxylamine—Hyperhidrosis—Paclitaxel—kidney cancer	0.00103	0.00104	CcSEcCtD
Doxylamine—Diarrhoea—Dactinomycin—kidney cancer	0.00103	0.00104	CcSEcCtD
Doxylamine—Nasopharyngitis—Doxorubicin—kidney cancer	0.00103	0.00104	CcSEcCtD
Doxylamine—Anorexia—Paclitaxel—kidney cancer	0.00102	0.00103	CcSEcCtD
Doxylamine—Vomiting—Sunitinib—kidney cancer	0.00101	0.00102	CcSEcCtD
Doxylamine—Tremor—Capecitabine—kidney cancer	0.001	0.00102	CcSEcCtD
Doxylamine—Rash—Sunitinib—kidney cancer	0.001	0.00101	CcSEcCtD
Doxylamine—Dermatitis—Sunitinib—kidney cancer	0.000999	0.00101	CcSEcCtD
Doxylamine—Hypotension—Paclitaxel—kidney cancer	0.000995	0.00101	CcSEcCtD
Doxylamine—Ill-defined disorder—Capecitabine—kidney cancer	0.000994	0.00101	CcSEcCtD
Doxylamine—Hypersensitivity—Vincristine—kidney cancer	0.000988	0.001	CcSEcCtD
Doxylamine—Nausea—Sorafenib—kidney cancer	0.000979	0.000991	CcSEcCtD
Doxylamine—Pancreatitis—Doxorubicin—kidney cancer	0.000971	0.000984	CcSEcCtD
Doxylamine—Malaise—Capecitabine—kidney cancer	0.000966	0.000978	CcSEcCtD
Doxylamine—Insomnia—Paclitaxel—kidney cancer	0.000963	0.000976	CcSEcCtD
Doxylamine—Vertigo—Capecitabine—kidney cancer	0.000962	0.000975	CcSEcCtD
Doxylamine—Asthenia—Vincristine—kidney cancer	0.000962	0.000975	CcSEcCtD
Doxylamine—Leukopenia—Capecitabine—kidney cancer	0.000959	0.000971	CcSEcCtD
Doxylamine—Vomiting—Dactinomycin—kidney cancer	0.000954	0.000967	CcSEcCtD
Doxylamine—Dyspnoea—Paclitaxel—kidney cancer	0.00095	0.000962	CcSEcCtD
Doxylamine—Somnolence—Paclitaxel—kidney cancer	0.000947	0.000959	CcSEcCtD
Doxylamine—Palpitations—Capecitabine—kidney cancer	0.000947	0.000959	CcSEcCtD
Doxylamine—Rash—Dactinomycin—kidney cancer	0.000946	0.000959	CcSEcCtD
Doxylamine—Nausea—Sunitinib—kidney cancer	0.000942	0.000954	CcSEcCtD
Doxylamine—Pancytopenia—Doxorubicin—kidney cancer	0.000941	0.000953	CcSEcCtD
Doxylamine—Decreased appetite—Paclitaxel—kidney cancer	0.000926	0.000938	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.00092	0.000931	CcSEcCtD
Doxylamine—Fatigue—Paclitaxel—kidney cancer	0.000918	0.00093	CcSEcCtD
Doxylamine—Diarrhoea—Vincristine—kidney cancer	0.000918	0.000929	CcSEcCtD
Doxylamine—Asthenia—Gemcitabine—kidney cancer	0.000913	0.000925	CcSEcCtD
Doxylamine—Constipation—Paclitaxel—kidney cancer	0.000911	0.000923	CcSEcCtD
Doxylamine—Anxiety—Capecitabine—kidney cancer	0.000909	0.00092	CcSEcCtD
Doxylamine—Discomfort—Capecitabine—kidney cancer	0.000901	0.000912	CcSEcCtD
Doxylamine—Pruritus—Gemcitabine—kidney cancer	0.0009	0.000912	CcSEcCtD
Doxylamine—Dry mouth—Capecitabine—kidney cancer	0.000892	0.000903	CcSEcCtD
Doxylamine—Nausea—Dactinomycin—kidney cancer	0.000892	0.000903	CcSEcCtD
Doxylamine—Diphenhydramine—PTGS1—kidney cancer	0.000887	0.0701	CrCbGaD
Doxylamine—Dizziness—Vincristine—kidney cancer	0.000887	0.000898	CcSEcCtD
Doxylamine—Drowsiness—Doxorubicin—kidney cancer	0.000883	0.000895	CcSEcCtD
Doxylamine—Confusional state—Capecitabine—kidney cancer	0.000881	0.000893	CcSEcCtD
Doxylamine—Feeling abnormal—Paclitaxel—kidney cancer	0.000878	0.000889	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000876	0.000887	CcSEcCtD
Doxylamine—Diarrhoea—Gemcitabine—kidney cancer	0.00087	0.000882	CcSEcCtD
Doxylamine—Nervous system disorder—Capecitabine—kidney cancer	0.000857	0.000868	CcSEcCtD
Doxylamine—Thrombocytopenia—Capecitabine—kidney cancer	0.000856	0.000867	CcSEcCtD
Doxylamine—Tachycardia—Capecitabine—kidney cancer	0.000853	0.000864	CcSEcCtD
Doxylamine—Vomiting—Vincristine—kidney cancer	0.000853	0.000864	CcSEcCtD
Doxylamine—Sweating—Doxorubicin—kidney cancer	0.000847	0.000858	CcSEcCtD
Doxylamine—Urticaria—Paclitaxel—kidney cancer	0.000846	0.000857	CcSEcCtD
Doxylamine—Rash—Vincristine—kidney cancer	0.000846	0.000856	CcSEcCtD
Doxylamine—Hyperhidrosis—Capecitabine—kidney cancer	0.000845	0.000856	CcSEcCtD
Doxylamine—Dermatitis—Vincristine—kidney cancer	0.000845	0.000856	CcSEcCtD
Doxylamine—Anorexia—Capecitabine—kidney cancer	0.000833	0.000844	CcSEcCtD
Doxylamine—Agranulocytosis—Doxorubicin—kidney cancer	0.000824	0.000835	CcSEcCtD
Doxylamine—Hypotension—Capecitabine—kidney cancer	0.000817	0.000827	CcSEcCtD
Doxylamine—Vomiting—Gemcitabine—kidney cancer	0.000809	0.000819	CcSEcCtD
Doxylamine—Bradycardia—Doxorubicin—kidney cancer	0.000807	0.000818	CcSEcCtD
Doxylamine—Rash—Gemcitabine—kidney cancer	0.000802	0.000812	CcSEcCtD
Doxylamine—Dermatitis—Gemcitabine—kidney cancer	0.000801	0.000812	CcSEcCtD
Doxylamine—Nausea—Vincristine—kidney cancer	0.000797	0.000807	CcSEcCtD
Doxylamine—Hepatitis—Doxorubicin—kidney cancer	0.000793	0.000803	CcSEcCtD
Doxylamine—Insomnia—Capecitabine—kidney cancer	0.000791	0.000801	CcSEcCtD
Doxylamine—Tamoxifen—CYP1A1—kidney cancer	0.00079	0.0624	CrCbGaD
Doxylamine—Hypersensitivity—Paclitaxel—kidney cancer	0.000785	0.000795	CcSEcCtD
Doxylamine—Urinary tract disorder—Doxorubicin—kidney cancer	0.000783	0.000793	CcSEcCtD
Doxylamine—Dyspnoea—Capecitabine—kidney cancer	0.000779	0.000789	CcSEcCtD
Doxylamine—Urethral disorder—Doxorubicin—kidney cancer	0.000777	0.000787	CcSEcCtD
Doxylamine—Asthenia—Paclitaxel—kidney cancer	0.000764	0.000774	CcSEcCtD
Doxylamine—Decreased appetite—Capecitabine—kidney cancer	0.00076	0.00077	CcSEcCtD
Doxylamine—Nausea—Gemcitabine—kidney cancer	0.000756	0.000765	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000755	0.000764	CcSEcCtD
Doxylamine—Fatigue—Capecitabine—kidney cancer	0.000754	0.000763	CcSEcCtD
Doxylamine—Pruritus—Paclitaxel—kidney cancer	0.000754	0.000763	CcSEcCtD
Doxylamine—Erythema multiforme—Doxorubicin—kidney cancer	0.00075	0.00076	CcSEcCtD
Doxylamine—Constipation—Capecitabine—kidney cancer	0.000748	0.000757	CcSEcCtD
Doxylamine—Eye disorder—Doxorubicin—kidney cancer	0.000741	0.000751	CcSEcCtD
Doxylamine—Cardiac disorder—Doxorubicin—kidney cancer	0.000736	0.000746	CcSEcCtD
Doxylamine—Flushing—Doxorubicin—kidney cancer	0.000736	0.000746	CcSEcCtD
Doxylamine—Diarrhoea—Paclitaxel—kidney cancer	0.000729	0.000738	CcSEcCtD
Doxylamine—Feeling abnormal—Capecitabine—kidney cancer	0.00072	0.00073	CcSEcCtD
Doxylamine—Immune system disorder—Doxorubicin—kidney cancer	0.000716	0.000726	CcSEcCtD
Doxylamine—Mediastinal disorder—Doxorubicin—kidney cancer	0.000715	0.000724	CcSEcCtD
Doxylamine—Dizziness—Paclitaxel—kidney cancer	0.000704	0.000713	CcSEcCtD
Doxylamine—Urticaria—Capecitabine—kidney cancer	0.000694	0.000703	CcSEcCtD
Doxylamine—Erythema—Doxorubicin—kidney cancer	0.00069	0.000699	CcSEcCtD
Doxylamine—Vomiting—Paclitaxel—kidney cancer	0.000677	0.000686	CcSEcCtD
Doxylamine—Rash—Paclitaxel—kidney cancer	0.000672	0.00068	CcSEcCtD
Doxylamine—Dermatitis—Paclitaxel—kidney cancer	0.000671	0.00068	CcSEcCtD
Doxylamine—Muscle spasms—Doxorubicin—kidney cancer	0.000664	0.000672	CcSEcCtD
Doxylamine—Hypersensitivity—Capecitabine—kidney cancer	0.000644	0.000652	CcSEcCtD
Doxylamine—Ill-defined disorder—Doxorubicin—kidney cancer	0.000641	0.000649	CcSEcCtD
Doxylamine—Agitation—Doxorubicin—kidney cancer	0.000634	0.000643	CcSEcCtD
Doxylamine—Nausea—Paclitaxel—kidney cancer	0.000633	0.000641	CcSEcCtD
Doxylamine—Asthenia—Capecitabine—kidney cancer	0.000627	0.000635	CcSEcCtD
Doxylamine—Malaise—Doxorubicin—kidney cancer	0.000623	0.000631	CcSEcCtD
Doxylamine—Vertigo—Doxorubicin—kidney cancer	0.00062	0.000628	CcSEcCtD
Doxylamine—Pruritus—Capecitabine—kidney cancer	0.000618	0.000626	CcSEcCtD
Doxylamine—Leukopenia—Doxorubicin—kidney cancer	0.000618	0.000626	CcSEcCtD
Doxylamine—Palpitations—Doxorubicin—kidney cancer	0.00061	0.000618	CcSEcCtD
Doxylamine—Convulsion—Doxorubicin—kidney cancer	0.000598	0.000606	CcSEcCtD
Doxylamine—Diarrhoea—Capecitabine—kidney cancer	0.000598	0.000606	CcSEcCtD
Doxylamine—Anxiety—Doxorubicin—kidney cancer	0.000586	0.000593	CcSEcCtD
Doxylamine—Discomfort—Doxorubicin—kidney cancer	0.000581	0.000588	CcSEcCtD
Doxylamine—Dizziness—Capecitabine—kidney cancer	0.000578	0.000585	CcSEcCtD
Doxylamine—Dry mouth—Doxorubicin—kidney cancer	0.000575	0.000582	CcSEcCtD
Doxylamine—Confusional state—Doxorubicin—kidney cancer	0.000568	0.000575	CcSEcCtD
Doxylamine—Anaphylactic shock—Doxorubicin—kidney cancer	0.000563	0.000571	CcSEcCtD
Doxylamine—Vomiting—Capecitabine—kidney cancer	0.000556	0.000563	CcSEcCtD
Doxylamine—Nervous system disorder—Doxorubicin—kidney cancer	0.000553	0.00056	CcSEcCtD
Doxylamine—Thrombocytopenia—Doxorubicin—kidney cancer	0.000552	0.000559	CcSEcCtD
Doxylamine—Rash—Capecitabine—kidney cancer	0.000551	0.000558	CcSEcCtD
Doxylamine—Dermatitis—Capecitabine—kidney cancer	0.000551	0.000558	CcSEcCtD
Doxylamine—Tachycardia—Doxorubicin—kidney cancer	0.00055	0.000557	CcSEcCtD
Doxylamine—Hyperhidrosis—Doxorubicin—kidney cancer	0.000545	0.000552	CcSEcCtD
Doxylamine—Anorexia—Doxorubicin—kidney cancer	0.000537	0.000544	CcSEcCtD
Doxylamine—Hypotension—Doxorubicin—kidney cancer	0.000527	0.000533	CcSEcCtD
Doxylamine—Nausea—Capecitabine—kidney cancer	0.000519	0.000526	CcSEcCtD
Doxylamine—Insomnia—Doxorubicin—kidney cancer	0.00051	0.000516	CcSEcCtD
Doxylamine—Dyspnoea—Doxorubicin—kidney cancer	0.000502	0.000509	CcSEcCtD
Doxylamine—Somnolence—Doxorubicin—kidney cancer	0.000501	0.000507	CcSEcCtD
Doxylamine—Decreased appetite—Doxorubicin—kidney cancer	0.00049	0.000496	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000486	0.000493	CcSEcCtD
Doxylamine—Fatigue—Doxorubicin—kidney cancer	0.000486	0.000492	CcSEcCtD
Doxylamine—Constipation—Doxorubicin—kidney cancer	0.000482	0.000488	CcSEcCtD
Doxylamine—Feeling abnormal—Doxorubicin—kidney cancer	0.000464	0.00047	CcSEcCtD
Doxylamine—Urticaria—Doxorubicin—kidney cancer	0.000448	0.000453	CcSEcCtD
Doxylamine—Tamoxifen—ABCB1—kidney cancer	0.00042	0.0332	CrCbGaD
Doxylamine—Doxepin—ABCB1—kidney cancer	0.000418	0.033	CrCbGaD
Doxylamine—Methadone—ABCB1—kidney cancer	0.000416	0.0329	CrCbGaD
Doxylamine—Hypersensitivity—Doxorubicin—kidney cancer	0.000415	0.00042	CcSEcCtD
Doxylamine—Asthenia—Doxorubicin—kidney cancer	0.000404	0.000409	CcSEcCtD
Doxylamine—Pruritus—Doxorubicin—kidney cancer	0.000399	0.000404	CcSEcCtD
Doxylamine—Diarrhoea—Doxorubicin—kidney cancer	0.000386	0.00039	CcSEcCtD
Doxylamine—Dizziness—Doxorubicin—kidney cancer	0.000373	0.000377	CcSEcCtD
Doxylamine—Vomiting—Doxorubicin—kidney cancer	0.000358	0.000363	CcSEcCtD
Doxylamine—Rash—Doxorubicin—kidney cancer	0.000355	0.00036	CcSEcCtD
Doxylamine—Dermatitis—Doxorubicin—kidney cancer	0.000355	0.00036	CcSEcCtD
Doxylamine—Nausea—Doxorubicin—kidney cancer	0.000335	0.000339	CcSEcCtD
Doxylamine—Imipramine—ABCB1—kidney cancer	0.000326	0.0257	CrCbGaD
Doxylamine—Amitriptyline—ABCB1—kidney cancer	0.000324	0.0256	CrCbGaD
